Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status

Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2) induced Coronavirus Disease - 19 (COVID-19) cases have been increasing at an alarming rate (7.4 million positive cases as on June 11 2020), causing high mortality (4,17,956 deaths as on June 11 2020) and economic loss (a 3.2% shrink in gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Beeraka, Narasimha M., Sadhu, Surya P., Madhunapantula, SubbaRao V., Rao Pragada, Rajeswara, Svistunov, Andrey A., Nikolenko, Vladimir N., Mikhaleva, Liudmila M., Aliev, Gjumrakch
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531039/
https://www.ncbi.nlm.nih.gov/pubmed/33072093
http://dx.doi.org/10.3389/fimmu.2020.552925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531039/
https://www.ncbi.nlm.nih.gov/pubmed/33072093
http://dx.doi.org/10.3389/fimmu.2020.552925

Ejemplares similares